Axonics, Inc. (NASDAQ:AXNX) Q1 2023 Earnings Call Transcript

Raymond Cohen : Alright. Well, thank you, operator. We appreciate that. So in closing, I just like to say that, we remain grateful for the trust the physicians, patients and shareholders have placed in Axonics. And as always, I’d like to thank my colleagues in Irvine and our team in the field for their diligent efforts and dedication to the fulfilling Axonic’s mission of improving the lives of adults with incontinence. And, I would just finish by saying, look, we really appreciate the continued interest in Axonics. We appreciate everybody’s questions for today. And we look forward to having a strong Q2 and speaking with you after the dust settles. Thank you so much.

Operator: Thank you, ladies and gentlemen, for your participation in today’s conference. This does conclude the program. You may now disconnect. Good day.